Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention.
about
Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@en
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@nl
type
label
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@en
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@nl
prefLabel
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@en
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@nl
P2860
P356
P1433
P1476
Nonalcoholic fatty liver disea ...... pharmacological intervention.
@en
P2093
Carlos J Pirola
Silvia Sookoian
P2860
P304
P356
10.1002/HEP.28866
P407
P577
2016-10-13T00:00:00Z